David Topper - Chief Financial Officer at Arcutis Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
ARQT on Nasdaq
All Insider Reports
All Insider Reports

David Topper - trading volume in the past year for Arcutis Biotherapeutics, Inc.

Holdings reported by David Topper for Arcutis Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 182,774 $2,888,176 $15.80 02 Apr 2025 Direct
Stock Option (right to buy) 89,000 28 Feb 2025 Direct Common Stock

Transactions reported by David Topper for Arcutis Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.